Volume 89 Issue 26 | p. 17 | Concentrates
Issue Date: June 27, 2011

Sanofi, Audion plan Hearing-Loss Drugs

Department: Business
Keywords: regenerative treatment, hearing loss

Sanofi and Amsterdam-based Audion Therapeutics have formed a two-year research collaboration to develop small-molecule-based regenerative treatments for hearing loss. The collaboration will use technology developed at the Eaton-Peabody Laboratories of the Massachusetts Eye & Ear Infirmary by Albert Edge, cofounder of Audion. According to Sanofi, there are currently no prescription products for a disease-modifying treatment for hearing loss.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment